证券代码：839273 证券简称：一致魔芋 公告编号：2024-017 湖北一致魔芋生物科技股份有限公司 2023 年年度募集资金存放与实际使用情况的专项报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、募集资金基本情况 （一）募集资金总额、净额及资金到账时间 2023 年 1 月 5 日，中国证券监督管理委员会出具《关于同意湖北一致魔芋 生物科技股份有限公司向不特定合格投资者公开发行股票注册的批复》(证监许 可[2023]18 号)，同意公司向不特定合格投资者公开发行股票的注册申请。 公司本次发行价格为 11.38 元/股，发行股数为 1,350.00 万股，募集资金总 额 15,363.00 万元，扣除发行费用募集资金净额为 13,948.57 万元。截至 2023 年 2 月 10 日，上述募集资金已全部到账。天健会计师事务所（特殊普通合伙） 对上述募集资金到位情况进行了审验，并出具了（天健验（2023）10-1 号）《验 资报告》。 截至 2023 年 12 月 31 日，本公司有 2 ...

Share Capital and Listing - The company reported a total share capital of 73,754,000 shares as of December 31, 2023[20]. - The company successfully listed on the Beijing Stock Exchange on February 21, 2023, with an initial public offering of 13,500,000 shares, which was later increased to 15,525,000 shares after the exercise of the over-allotment option[20]. - The company’s registered capital is 73,754,000 RMB, reflecting its financial stability and growth potential[20]. Business Operations - The company’s main business includes deep processing of konjac and related product research and development, with major products being konjac hydrophilic colloids, konjac food, and konjac beauty products[18]. - The company has expanded its operational scope and updated its business registration in compliance with regulatory requirements[23]. - The company focuses on both domestic and international sales, with domestic sales increasing while international sales faced challenges due to inflation and reduced market demand[45]. Financial Performance - The company's operating revenue for 2023 was ¥478,823,062.43, representing a year-over-year increase of 7.03% compared to ¥447,353,301.41 in 2022[27]. - The net profit attributable to shareholders decreased by 19.23% to ¥52,743,636.75 from ¥65,300,803.21 in the previous year[27]. - Total assets increased by 17.26% to ¥641,885,921.84 from ¥547,418,014.11 at the end of 2022[28]. - Total liabilities decreased significantly by 54.94% to ¥76,020,669.83 from ¥168,702,905.67 in the previous year[28]. - The net asset attributable to shareholders rose by 49.37% to ¥566,054,357.30 compared to ¥378,949,336.31 at the end of 2022[28]. Research and Development - The company invested ¥17,995,781.35 in R&D, marking a 10.17% increase year-on-year, and holds a total of 81 intellectual property rights, including 21 invention patents[46]. - The company has formed R&D partnerships with institutions such as Shanghai Jiao Tong University and Wuhan University of Light Industry to enhance product development capabilities[43]. - The company is expanding into plant-based personal care products, with two new products developed and a patent application submitted, addressing consumer demand for health and environmentally friendly products[88]. Risk Management - The company emphasizes the importance of risk awareness among investors regarding forward-looking statements in its annual report[9]. - The company has established a market risk early warning mechanism to respond promptly to market changes[115]. - The company faces significant risks from raw material price fluctuations, which can impact production costs and profitability[115]. Corporate Governance - The company’s actual controller is Wu Ping, with Li Li as a co-controller, ensuring a clear governance structure[19]. - The company has engaged Zhonghui Certified Public Accountants for auditing, ensuring the accuracy and reliability of its financial reports[21]. - The company has not identified any delisting risks, indicating a stable market position[11]. Inventory and Cash Flow - Inventory decreased by 19.74% to ¥269,513,486.88, accounting for 41.99% of total assets, compared to 61.34% in the previous year[51]. - The cash flow from operating activities improved significantly, reaching ¥145,885,860.60, a 264.43% increase from a negative cash flow of ¥88,719,695.63 in 2022[28]. Market Position and Growth - The market for konjac deep-processing products has seen an average annual compound growth rate of 26% over the past decade, indicating strong market potential[49]. - The company is positioned to capitalize on the growing demand for healthy food products, with konjac products being a key focus area[49]. - The company has been recognized as a "National Key Leading Enterprise in Agricultural Industrialization" and a "Hubei Province Hidden Champion Demonstration Enterprise" by various government bodies[44]. Share Repurchase and Commitments - The company has initiated a share repurchase plan with a total amount between ¥12,000,000 and ¥24,000,000, aiming to buy back 1,000,000 to 2,000,000 shares, representing 1.36% to 2.71% of the total share capital[126]. - The company has completed the necessary preparations for the share repurchase, including opening dedicated securities and fund accounts[127]. - The company plans to use the repurchased shares for employee stock ownership plans or equity incentives[128]. Compliance and Regulatory Matters - The company has committed to ensuring the authenticity, accuracy, and completeness of its financial disclosures, including the prospectus and other related documents[188]. - The company will ensure compliance with information disclosure obligations when reducing shareholdings[143]. - The company has pledged to voluntarily restrict the sale of shares for six months following any serious violations, such as fund occupation or false statements[198].

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [7] Core Views - The company reported a revenue of 479 million yuan in 2023, representing a year-on-year growth of 7.06%, while the net profit attributable to the parent company was 59.21 million yuan, a decline of 9.33% compared to the previous year. The decrease in net profit was attributed to a larger decline in product sales prices compared to the decrease in raw material costs, leading to a drop in gross margin [7] - The company is expanding its production capacity by investing 100 million yuan in a new project to produce 80,000 tons of tea beverage materials annually, which is expected to enhance its market competitiveness and profitability [7][19] - The company plans to establish a wholly-owned subsidiary in Hong Kong to enhance its international competitiveness and support its global development strategy [7][19] Financial Performance Summary - In 2023, the company's main products, konjac powder and konjac food, saw an increase in sales volume, while sales prices decreased. The sales revenue from konjac beauty products dropped by 58.46% due to reduced demand in overseas markets [8] - The company anticipates a decline in net profit for 2023-2025, with projected figures of 59 million yuan (originally 68 million yuan), 63 million yuan (originally 86 million yuan), and 72 million yuan (originally 95 million yuan) respectively. The corresponding EPS is expected to be 0.80, 0.85, and 0.98 yuan per share [7][8] - The company is focusing on expanding its applications in the konjac powder, compound powder, and downstream konjac product processing sectors, particularly in jelly, ingredients, and tea beverage industries [8]

证券代码：839273 证券简称：一致魔芋 公告编号：2024-012 湖北一致魔芋生物科技股份有限公司 关于全资子公司完成工商变更登记并取得营业执照的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一致嘉纤工商登记信息具体变更如下： | 变更项目 | 变更前 | 变更后 | | --- | --- | --- | | | 薯类食品、酱腌菜、食用菌 | 一般项目：工程和技术研究和试验发展 | | | 制品、方便食品、水果制 | (除人体干细胞、基因诊断与治疗技术 | | | 品、调味品的生产与销售； | 开发和应用，中国稀有和特有的珍贵优 | | | 生物产品科技研究与开发； | 良品种),技术服务、技术开发、技术咨 | | | 货物进出口贸易（法律、行 | 询、技术交流、技术转让、技术推广， | | 经营范围 | 政法规禁止、限制以及指定 | 货物进出口，非居住房地产租赁。（除 | | | 经营的进出口项目除外）;房 | 许可业务外，可自主依法经营法律法规 | | | 屋及仓库出租（依法须经批 ...

证券代码：839273 证券简称：一致魔芋 公告编号：2024-011 湖北一致魔芋生物科技股份有限公司 回购进展情况公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、 回购方案基本情况 湖北一致魔芋生物科技股份有限公司（以下简称"公司"）于 2023 年 8 月 16 日召 开公司第三届董事会第七次会议、第三届监事会第六次会议，并于 2023 年 9 月 5 日召 开 2023 年第一次临时股东大会，审议通过了《关于公司回购股份方案的议案》，公司现 任独立董事对本项议案发表了同意的独立意见。回购方案的主要情况如下： （一） 回购用途及目的 基于对公司未来发展的信心和对公司价值的认可，提升公司股票长期投资价值，综 合考虑公司经营情况、财务状况以及未来的盈利能力等因素，公司拟以自有资金回购公 司股份。本次回购的股份将用于实施股权激励或员工持股计划，以此进一步完善公司治 结构，构建长期激励与约束机制，确保公司长期经营目标的实现，提升公司整体价值。 （二） 回购方式 本次回购方式为竞价方式回购。 自董事 ...

Financial Performance - The company achieved operating revenue of 478,933,777.23 yuan, a year-on-year increase of 7.06%[4] - Net profit attributable to shareholders decreased by 9.33% to 59,208,452.31 yuan, while the net profit after deducting non-recurring gains and losses fell by 35.82% to 37,218,670.68 yuan[6] - Basic earnings per share dropped by 28.57% to 0.80 yuan, primarily due to a decrease in net profit and an increase in total shares from 58,229,000 to 73,754,000[8] Assets and Equity - Total assets increased by 18.00% to 645,966,266.53 yuan, driven by the arrival of raised funds and new construction projects[8] - Shareholders' equity attributable to the company rose by 51.08% to 572,519,172.86 yuan, mainly due to the funds raised from the listing on the Beijing Stock Exchange[8] Profitability and Margins - The company recorded a decrease in gross profit margin due to a larger decline in product sales prices compared to the decrease in raw material costs[7] - Inventory impairment provision of 4,029,800 yuan was recognized based on impairment testing of significant assets[7] Market Performance - The company noted that domestic sales revenue increased, while overseas sales revenue decreased due to inflation and reduced market demand[7] Cautionary Note - Investors are advised to exercise caution as the financial data is preliminary and unaudited, with final figures to be disclosed in the annual report[9]

证券代码：839273 证券简称：一致魔芋 公告编号：2024-009 湖北一致魔芋生物科技股份有限公司 关于延长公司股东股份锁定期的公告 4.本人将严格根据中国证监会、北京证券交易所等有权部门颁布的相关法律、 法规及规范性文件的有关规定，履行相关股份锁定承诺事项，在法律、法规及中 国证监会、北京证券交易所等有权部门颁布的相关规范性文件的有关规定以及股 份锁定承诺规定的限售期内，不进行任何违反相关规定及股份锁定承诺的股份减 持行为。 湖北一致魔芋生物科技股份有限公司（以下简称"公司"）于 2023 年 1 月 5 日收到中国证券监督管理委员会下发的《关于同意湖北一致魔芋生物科技股份 有限公司向不特定合格投资者公开发行股票注册的批复》（证监许可〔2023〕18 号），同意公司向不特定合格投资者公开发行股票的注册申请。2023 年 2 月 15 日，北京证券交易所出具《关于同意湖北一致魔芋生物科技股份有限公司股票在 北京证券交易所上市的函》（北证函〔2023〕48 号），公司股票于 2023 年 2 月 21 日在北京证券交易所上市。 本次公开发行前，公司控股股东、实际控制人及亲属、董事、高级管理人员、 实际控制 ...

Group 1: Company Overview - Hubei Yizhi Konjac Biotechnology Co., Ltd. focuses on deep processing of konjac and has transferred 100% equity of Hubei Zhili Konjac Seed Industry Co., Ltd. to concentrate resources on its main business [4] - The company has established a stable management team and emphasizes research and development, combining independent and collaborative efforts to innovate products [7] Group 2: Product and Market Strategy - The company's revenue structure is primarily B-end, with plans to develop its own brands alongside brand OEM and ODM, including "Molege" and "Yizhi" for fast-moving consumer goods [5] - Konjac products include snacks, convenience foods, dietary fiber, pre-prepared meals, and tea additives, with a strong sales presence in Hubei province through various channels [6] Group 3: Supply Chain and Procurement - Raw material procurement is seasonal, mainly from September to March, with a shelf life of at least 18 months for raw materials and 2 years for finished products [7] - The company maintains stable supply chains by establishing long-term partnerships with suppliers in major konjac production areas and providing initial processing equipment and technical guidance [8] Group 4: Competitive Advantages - The company has developed three main product lines: konjac gel, konjac foods, and konjac beauty products, with a strong market position recognized by clients and authorities [7] - Brand recognition is a key asset, with the "Yizhi" trademark recognized as a famous brand in China, built through years of focus on quality and innovation [8]

证券代码：839273 证券简称：一致魔芋 公告编号：2024-007 湖北一致魔芋生物科技股份有限公司 回购进展情况公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、 回购方案基本情况 公司董事会审议通过回购股份方案前 30 个交易日（不含停牌日）交易均价为 9.97 元，拟回购价格上限不低于上述价格，不高于上述价格的 200%。 湖北一致魔芋生物科技股份有限公司（以下简称"公司"）于 2023 年 8 月 16 日召 开公司第三届董事会第七次会议、第三届监事会第六次会议，并于 2023 年 9 月 5 日召 开 2023 年第一次临时股东大会，审议通过了《关于公司回购股份方案的议案》，公司现 任独立董事对本项议案发表了同意的独立意见。回购方案的主要情况如下： （一） 回购用途及目的 基于对公司未来发展的信心和对公司价值的认可，提升公司股票长期投资价值，综 合考虑公司经营情况、财务状况以及未来的盈利能力等因素，公司拟以自有资金回购公 司股份。本次回购的股份将用于实施股权激励或员工持股计划，以此进 ...

湖北陈守邦律师事务所 关于湖北一致魔芋生物科技股份有限公司 2024 年第一次临时股东大会的 法律意见书 湖北陈守邦律师事务 CHENSHOUBANG LAWFIRM HUBEI 地址：湖北省宜昌市发展大道 57-6 号三峡云计算中心 B 座 17 层 电话: 0717-6900007 邮编：443005 l 湖北陈守邦律师事务所 法律意见书 基于上述,本所律师依据《证券法》《律师事务所从事证券法律业务管理办 法》《律师事务所证券法律业务执业规则(试行)》的相关规定以及本法律意见书 出具之日以前已经发生或者存在的事实,严格履行了法定职责,按照律师行业公 认的业务标准、道德规范和勤勉尽责的精神,进行了充分的核查验证,就题述事 项发表法律意见,并在公司提供文件、披露公告及其签章、内容均真实、准确、 完整、有效,不存在任何虚假记载、误导性陈述或者重大遗漏，且文件副本、复 印件均与原件一致的前提下,保证本法律意见书所认定的事实真实、准确、完整, 2 湖北陈守邦律师事务所 湖北陈守邦律师事务所 关于湖北一致魔芋生物科技股份有限公司 2024 年第一次临时股东大会的 法律意见书 致:湖北一致魔芋生物科技股份有限公司 湖北 ...